Literature DB >> 6223882

Siderophore production by Vibrio vulnificus.

L M Simpson, J D Oliver.   

Abstract

Previous studies in our laboratory, as well as clinical evidence, have suggested that increased iron levels in the host may be important in infections caused by the halophilic pathogen Vibrio vulnificus. To study iron acquisition, we induced siderophore production by growth in a low-iron medium, and biochemical testing indicated the production of both hydroxamate- and phenolate-type siderophores. The siderophores were extracted from growth filtrates with ethyl acetate (for phenolates) and phenol-chloroform-ether (for hydroxamates). These extracts enhanced the growth of V. vulnificus when the bacterium was grown in iron-limited medium. The ability of these siderophores to stimulate the growth of Salmonella typhimurium LT-2 enb-7 (a mutant deficient in the biosynthesis of enterochelin) and Arthrobacter flavescens JG-9 (a hydroxamate auxotroph) supported the conclusion that V. vulnificus produces both hydroxamate- and phenolate-type siderophores.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223882      PMCID: PMC264691          DOI: 10.1128/iai.41.2.644-649.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Siderophore production by Vibrio cholerae.

Authors:  S M Payne; R A Finkelstein
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 2.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

Review 3.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

4.  Siderophore production by Enterobacter cloacae and a common receptor protein for the uptake of aerobactin and cloacin DF13.

Authors:  G J Van Tiel-Menkveld; J M Mentjox-Vervuurt; B Oudega; F K de Graaf
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

5.  Effects of injected iron and siderophores on infections in normal and immune mice.

Authors:  I Kochan; J Wasynczuk; M A McCabe
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Halophilic vibrios from human tissue infections on the pacific coast of Australia.

Authors:  H K Ghosh; T E Bowen
Journal:  Pathology       Date:  1980-07       Impact factor: 5.306

7.  Iron-controlled infection with Neisseria meningitidis in mice.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

8.  Lactose-positive Vibrio in seawater: a cause of pneumonia and septicemia in a drowning victim.

Authors:  M T Kelly; D M Avery
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

9.  Iron-Binding Catechols and Virulence in Escherichia coli.

Authors:  H J Rogers
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

10.  Role of iron in the pathogenesis of Vibrio vulnificus infections.

Authors:  A C Wright; L M Simpson; J D Oliver
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

View more
  53 in total

1.  Virulence characteristics of clinical and environmental isolates of Vibrio vulnificus.

Authors:  G N Stelma; A L Reyes; J T Peeler; C H Johnson; P L Spaulding
Journal:  Appl Environ Microbiol       Date:  1992-09       Impact factor: 4.792

2.  Cloning and sequence analysis of a novel hemolysin gene (vllY) from Vibrio vulnificus.

Authors:  T M Chang; Y C Chuang; J H Su; M C Chang
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

3.  Vibriobactin antibodies: a vaccine strategy.

Authors:  Raymond J Bergeron; Neelam Bharti; Shailendra Singh; James S McManis; Jan Wiegand; Linda G Green
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

Review 4.  Vibrio vulnificus: disease and pathogenesis.

Authors:  Melissa K Jones; James D Oliver
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

5.  Identification and characterization of a novel outer membrane protein receptor required for hemin utilization in Vibrio vulnificus.

Authors:  Shreya Datta; Jorge H Crosa
Journal:  Biometals       Date:  2011-10-21       Impact factor: 2.949

6.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

7.  Role of catechol siderophore synthesis in Vibrio vulnificus virulence.

Authors:  C M Litwin; T W Rayback; J Skinner
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

8.  Protection of mice against Vibrio vulnificus disease by vaccination with surface antigen preparations and anti-surface antigen antisera.

Authors:  A S Kreger; L D Gray; J Testa
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

9.  Role of iron, capsule, and toxins in the pathogenicity of Vibrio vulnificus biotype 2 for mice.

Authors:  C Amaro; E G Biosca; B Fouz; A E Toranzo; E Garay
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

Review 10.  Vibrio Iron Transport: Evolutionary Adaptation to Life in Multiple Environments.

Authors:  Shelley M Payne; Alexandra R Mey; Elizabeth E Wyckoff
Journal:  Microbiol Mol Biol Rev       Date:  2015-12-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.